bergmann-k-c 1

1. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
2. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
3. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
4. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model
5. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air^® real-world data
1